CD4 + T cell fate decisions 1 CD4 + T cell fate decisions are stochastic, precede cell division, depend on GITR co-1 stimulation, and are associated with uropodium development.
Introduction

Imaging Flow Cytometry 175
Samples were run on a 2 camera, 12 channel ImageStream X MkII (Amnis Corporation) with 176 the 60X Multimag objective and the Extended Depth of Field (EDF) option providing a 177 resolution of 0.3m per pixel and 16m depth of field. Fluorescent excitation lasers and 178 powers used were 405nm (50mW), 488nm (100mW) and 643nm (100mW) and the side 179 scatter laser was turned off to allow channel 6 to be used for PE-Cy7. The 448nm laser must 180 be used to excite all fluorophores emitting in channels 2-6, as any use of the 560nm laser 181 compromised multicolour compensation. Bright field images were captured on channels 1 182 and 9 (automatic power setting). A minimum of 30,000 images were acquired per sample 183 using INSPIRE 200 software (Amnis Corporation). Images containing beads were excluded 184 during acquisition as low intensity and high modulation of bright field channels 1 and 9. 185 Images were analysed using the IDEAS v 6.2 software (Amnis Corporation). Mito-ID-Red, which emit in both channels 4 and 5 and overlap with PE-CF594. All images 193 were initially gated for focus (using the Gradient RMS feature) on both bright field channels 194 (1 and 9) followed by selecting for singlet cells (DNA intensity/aspect ratio) and live cells at The strategy for making masks (blue shading) for nuclear expression and identification of 199 uropodia is shown in Figure 1A . The uropodium mask relies on the fact that irregular shaped 200 cells tend to align to the direction of laminar flow so the uropodium appears as a protrusion 201 that is aligned to plane of the 2D image of the cell. The bright field (Ch01) default mask 202 (M01) was first eroded, either by 2 pixels or, when a significant number of images contained 203 a lot of extraneous material (as seen at the bottom right of the example shown), by using an 204 80% adaptive erode (a) followed by a 5 pixel dilation, to generate a "clean" cell mask (b) . 205 The nuclear mask was then made using the morphology function of the DNA (eg. 7AAD, 255 Fix/Perm AlexaFluor488 Mouse anti-Tbet (BD Pharmingen 561266) Ch2
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Live after antigen stimulation, where the effector and memory cells fates can be distinguished by 267 differences in the surface expression of CD4 or CD8, differential PI3k/mTOR signalling, and 268 numbers or activity of mitochondria (9, 13, 38) . We used these observations to guide the 269 optimisation of an experimental setup summarised in Figure 2A . TCR transgenic, RAGKO 270 mice provided monoclonal populations of uniformly naïve CD4 + T cells that could be 271 analysed in detail after stimulation by their cognate antigen (the male antigen Dby). The
272
A1RAG strain (31) used for most of the in vitro studies reported here, has a low affinity TCR 273 expressed on the CBA/Ca background, but we also reproduced our findings with the 274 Marilyn.hCD2-Foxp3 (MARKI) strain (21) which has a TCR affinity approx. 10 times higher 275 (ie. requires 10 fold less peptide to achieve an equivalent response) and is on the C57BL/6 276 background.
277
Purified CD4 + T cells were cell trace violet (CTV) labelled and stimulated in vitro with bone 278 marrow derived dendritic cells (bmDC) and their cognate antigen (Dby) peptide (21, 31) . We 279 compared their responses to an antigen presenting cell free stimulation by anti-CD3 plus anti-280 CD28 coated beads. At the end of the primary culture, cells were stained for mitochondria 281 (Mitotracker DR), with conventional antibody labelling for cell surface CD4, plus 282 intracellular staining for pS6 as an indication of mTOR activation. We used both 283 conventional flow cytometry and imaging flow cytometry for analysis, with similar results, to 284 determine the optimal conditions for both mTOR activation and to identify conditions where 285 we could observe a similar bimodal distribution of CD4, mTOR activation and mitochondria 286 to that previously described (9, 13, 38) . Although standard RPMI+10% FCS culture medium 287 initially supported these observations, we found poor reproducibility especially with different 288 serum batches. For this reason, we moved to a more defined medium formulation (Advanced 289 RPMI) before further optimisation. An example optimisation experiment is shown in Figure   290 2B-D which examines some of the requirements of the tissue culture conditions, in this case 291 titrating the concentration of FCS, together with the addition of both IL-2 and TGFSection 292 3.10 gives further details on the role of these two cytokines Analysis was performed on day 3 293 (before nutrient depletion and intrinsic mTOR inhibition take place). Under these conditions,
294
1% FCS (as indeed recommended by the medium manufacturer) was optimal for both 295 bimodal mitochondria staining ( Figure 3C ) and maximal pS6/mTOR activation ( Figure 2D ).
296
This required bmDC/Dby peptide stimulation (at a previously determined optimal 297 concentration of 100nM for A1RAG T cells) while such bimodality was never observed with 298 anti-CD3/CD28 beads under any conditions tested. Note that while TGF suppressed 299 proliferation after CD3/CD28 stimulation (39), its addition gave a more reproducible bimodal 300 mitochondria staining with improved cell proliferation and survival when T cells were 301 stimulated with bmDC plus antigen. The addition of TGF also allowed us to compare fate 302 decisions of conventional and regulatory T cells subsets.
303
The bimodal mitochondrial distribution was found to be dependent on robust mTOR 304 activation, as rapamycin (mTORC1 inhibitor), Torin 1 (an inhibitor of total mTOR ATP-305 dependent activity) and amino acid starvation (30) all reduced the bimodality towards a 3.2 Optimisation of fixation and staining for imaging flow cytometry 309 Even with this optimised in vitro culture system, we still encountered issues of 310 reproducibility in the staining. We were unable to find any cells with the very distinctive 311 morphology of telophase -although we found images with some features of late cytokinesis, 312 but these could not be reliably distinguished from doublets and conjugates. Similarly, 313 although we often identified cells with uropodia, the reproducibility between experiments 314 was poor. We reasoned that both of these structural features were dependent on dynamic 315 metabolic processes that were being disrupted during cell harvesting and staining. For this 316 reason, we developed an "in situ" staining and fixation method (see methods). Our in vitro optimisation focussed on the bimodal mitochondrial distribution in A1RAG
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CD4 + T cells responding to antigen, but we needed to check if this remained relevant to in 328 vivo responses. We analysed draining lymph nodes from female A1RAG mice in mice 329 undergoing a secondary rejection of male skin grafts, where we reasoned we should see high 330 frequencies of both effector and memory CD4 + T cells. We compared this to the lack of 331 rejection in mice previously rendered tolerant of male skin (31). Figure 4A shows the 332 experimental design for these transplantation experiments. We had previously found very 333 few differences in the proliferative responses or cell surface phenotypes of CD4 + T cells from 334 the draining lymph nodes of both rejecting and tolerant mice (22, 40) , and here we also 335 observed similar levels of CD4 T cell activation, as indicated by high CD44 expression 336 ( Figure 4B , C). There were, however, striking differences in the cellular distribution of 337 mitochondria ( Figure 4D ). While T cells from tolerant mice had uniform numbers of We first tested whether the two populations with high or low mitochondrial staining were 350 transient and interconvertible, or represented two different cell fates. We did this by tracking 351 the inheritance of mitochondria pre-labelled with Mitotracker DR (which covalently labels 352 proteins within active mitochondria), that is then diluted as mitochondria partition into the 353 daughter cells after division, as shown in Figure 5A , B. By additionally labelling for total mitochondria with a different dye (Mito-ID-red) after fixation at the end of the experiment, 355 we could determine whether the cells with high or low mitochondria were generated by a 356 differential inheritance (ie. whether there was any deviation between Mitotracker DR and 357 CTV dilution during cell proliferation), and whether there was any mixing or interconversion 358 between the two populations. The high Mito-ID-red staining (total mitochondria) population, 359 which were also those with large uropodia ( Figure 5E ), showed a regular two-fold dilution of 360 the Mitotracker DR stain with each cell division ( Figure 5F ). In contrast, the population with 361 low Mito-ID-red staining did not develop significant uropodia, showed a considerable loss of 362 Mitotracker DR staining even before the first cell division, and thereafter continued regular 363 two-fold dilutions from this low level as cells proliferated ( Figure 5G ). This demonstrates 364 that two independent cell fates had been generated even before the first cell division that can 365 be distinguished readily by the numbers of mitochondria they possess, and this difference was 366 maintained and inherited through subsequent cell generations.
367
Those cells without uropodia, which had also lost mitochondria before the first cell division, 368 also lost some of their CTV staining at this same point ( Figure 5H ). One explanation for this 369 combined non-specific loss of two different covalent protein stains in cells destined for just 370 one of the two cell fates, and then only before the first cell division, might be a brief period of 371 autophagy/mitophagy (41). Inhibitors of autophagy (chloroquin or spautin 1) compromised 372 all T cell activation and proliferation, consequently blocking any opportunity to observe the 373 two cell fates (not shown), but we were able to detect increased staining with an autophagy 374 dye from 48h after stimulation, and before cell division, in the DC + Ag group ( Figure 5I ).
375
This represented about half of the cells that had increased both their size (ie. blasted) and 376 mitochondrial mass since first stimulated, but those cells destined to become memory cells 377 showed higher levels of autophagy associated with a subsequent loss of mitochondria (and 378 Mitotracker DR) as well as other cellular proteins (CTV label) before the first cell division. Figure 6A ), the two daughter cells are characteristically CD4 (or CD8) high versus 382 low (9), and differ in their numbers of mitochondria (38). The two populations generated 383 correspond to short-lived effector versus long-term memory cells (9, 11). Controversially (6, 384 37, 42), it is claimed that the binary nature of this fate decision is the result of an asymmetric 385 inheritance of various transcription factors (8, 10) and signalling components that drive these 386 diverging cell fates (13, 14) . Effector and memory T cells also differ in their PI3k/mTOR 387 signalling and metabolic profiles (12, 13, 43) , although uropodium development has not 388 previously been reported in this context. Our initial experiments had also appeared to support 389 this asymmetric model, but during the optimisation of staining and fixation methods we 390 realised that we had likely been misled by technical artefacts. After optimisation and flow 391 cell imaging analysis, we could objectively and unambiguously identify (see Figure 1H -N 392 gives the masking and gating strategy) all the images of rare cells in late anaphase and 393 telophase (without the use of any mitotic inhibitors) and accurately measure whether any cell Figure 6N ) at telophase, in neither the first, nor subsequent cell divisions, effectively ruling 399 out any role for asymmetric cell divisions in our system. This is consistent with the data of 400 Figure 5 and suggests a model where the decision to develop an effector cell fate (with uropodia development) takes place before the cells enter their first division, and the two cell 402 lineages then continue to proliferate in parallel ( Figure 6B ). 
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We confirmed that the structures we identified on the high mitochondrial staining cell showed clear staining at their base for the MTOC (-tubulin: Figure 8A , C), and were high in 419 CD44, 37% of which, on average, was located on the uropodium surface ( Figure 8F , K).
420
Uropodia also contained 50% of all the mitochondrial staining ( Figure 8E , J). In the cells 421 with uropodia, CD4 expression was also much higher and localised to the uropodium surface 422 ( Figure 8G , L). As shown above, uropodium development was associated with robust mTOR 423 activation and both mTORC1 (pS6) and mTORC2 (pAKTS473) (45, 46) levels were higher in 424 the cells that developed them ( Figure 8H , I), with the latter mostly localised within the 425 uropodium ( Figure 8N ). We found that across a wide range of Dby peptide concentrations ( Figure 9A , B; only two 430 extremes shown), two distinct populations of cells developed, one bearing uropodia and the 431 other lacking them, based on their measured area ( Figure 9F , G). The fact that we observed 432 two discrete populations of cells (either with or without uropodia rather than a continuum of 433 increasing uropodium size) suggests that individual T cells were still making a binary fate 434 decision, but in a manner that was stochastic and not determined by cell division. The chance 435 of an individual T cell developing an uropodium seemed to depend on the strength of 436 signalling through the mTOR pathway (as shown above, Figure 2G ) which led us to seek 437 evidence of discrete signalling states within this pathway that were associated with 438 uropodium development. Mathematical models suggest mechanisms by which such discrete 439 and stochastic signalling states may arise without pre-existing heterogeneity (47). When we 440 simultaneously stained for both mTORC1 (pS6) and mTORC2 (pAKTS473) signalling (48), 441 we reproducibly found a total of 6 distinct populations: 3 with weak/negative, intermediate or 
444
Cells with uropodia were found predominantly within the mTORC2 positive population that 445 were mTORC1 intermediate ( Figure 9F , G). The distribution of all CD4 + T cells across these 446 6 populations depended on the concentration of antigen/TCR stimulation, which mainly 447 increased mTORC1, while mTORC2 signalling required antigen presenting cells (bmDC: Figure 9C , D). Further analysis of the localisation of pAKTS473 confirmed that it was 449 specifically mTORC2 signalling that was localised to the uropodia rather than total AKT 450 ( Figure 9K , L, M) or PI3K signalling through pAKTT308 (not shown). The bmDC could 451 provide some mTORC2 signalling independent of TCR stimulation ( Figure 9E ). We also 452 found that total NFB p65 was strongly up-regulated with DC + antigen ( Figure 9Q ) in all 453 cells, but a specific increase in the nuclear localisation of NFB, indicating signalling, was 454 highest in the cells lacking uropodia ( Figure 9R ). Note that NFB signalling is thought to be 455 important for memory cell differentiation and maintenance (49). CD3/CD28 bead 456 stimulation, by comparison, was poor at upregulating total or nuclear NFB ( Figure 9Q , R), 457 despite inducing strong cell proliferation ( Figure 9P ). Figure 12B ), compatible with previous descriptions of foxp3 + regulatory cells 503 with some Thelper subset properties (54). Granzyme B, important for effector cell 504 cytotoxicity (55), was also expressed ( Figure 12G, H) , and tended to be localised to the 505 uropodia ( Figure 12I ), as previously described (44, 56) . Interestingly, where nuclear foxp3 506 was also present this localisation was reduced ( Figure 12I The cells in the lineage that had never developed uropodia survived and also proliferated until 516 nutrient limitation and mTOR inhibition occurred after day 4 (days 3 and 6 shown: Figure   517 13A-C). They continued to express high levels of both total and nuclear NFB even on day 7 518 ( Figure 13D-F) , which is thought to be important for the maintenance of memory T cells (49, 519 57, 58). These putative memory cells continued to survive in a quiescent state until at least 520 day 10 of culture, dependent on IL2 and promoted by TGF ( Figure 14A -E). By this time 521 almost all the effector cells with uropodia had died ( Figure 14D , E). We harvested (on day 6) 522 similar cultures (not previously CTV labelled) and re-stimulated them in fresh medium either 523 with CD3/CD28 beads or DC plus antigen. As expected for memory cells, a lower threshold 524 for activation was evidenced by the fact that CD3/CD28 beads, which were unable to induce 525 uropodia in the primary stimulation ( Figure 14I ), were sufficient in the secondary stimulation 526 to enable both proliferation and mTOR/pS6 upregulation (not shown) together with 527 uropodium development ( Figure 14G ). Regardless of the secondary stimulation, we could, 528 once again, observe two distinct populations (either with or without uropodia), suggesting 529 that memory cells make a further "activated/effector" versus "memory/stem" cell fate 530 decision. At the same time, while most of the cells continued to express CD44, a marker for 531 central memory cells (CD62L) was re-expressed on about half of the re-stimulated cells, 532 independent of whether they had developed uropodia or not ( Figure 14G, H) . This shows that 533 the memory T cells, upon re-stimulation, can apparently make further stochastic, 534 effector/memory-like fate decisions to naïve CD4 + T cells. Their T helper and regulatory cell 535 subset transcription factor expression was, however, very different to the random co-536 expression seen in the primary effector cells, with a much more restricted, singular pattern of 537 either Tbet or Foxp3 in the example shown in Figure 14F . 
Discussion
540
Optimising in vitro culture conditions, fixation, staining and analytical methods not CD44) and entry into cell division ( Figure 14C ). For routine experiments we added 589 sufficient exogenous IL2 such that intrinsic IL2 production would not be a confounding 590 variable to consider. The further addition of IL15 or related cytokines (IL7, IL4) did not 591 change the balance of uropodia expressing effector to memory cells (not shown). We also 592 observed both effector and memory cell populations under Th1 (anti-IL4 plus IFN) or Th2 593 (added IL4 plus anti-IL12) conditions (details not shown, although data from these conditions 594 are shown in Figure 6 ). The addition of active TGF was required for the long-term survival 595 of memory cells after DC + Ag stimulation, as well as any generation of foxp3 + Treg cells, 596 especially in the low (1%) serum cultures. A requirement for TGF for normal memory cell 597 development in vivo has previously been reported (49, 57, 58) . Uropodia development and a 598 bimodal mitochondrial distribution occurred within the first 48 hours after stimulation, and 599 before the initiation of cell proliferation under all the cytokine conditions that we tested.
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This seems incompatible with memory cells deriving from a few surviving effector cells. Yet, 601 two recent papers claim exactly that for viral specific memory cells after clinical vaccination 602 (60, 61). How can this be? The first paper makes the common (but we would suggest 603 incorrect) assumption that by labelling proliferating cells in a primary response that these 604 were all effector cells so that if memory cells in a secondary challenge were still labelled they 605 were presumed to derived from them. But we show here that during the primary response the 606 committed memory population are proliferating in parallel to the effector cells. The second 607 paper makes the same assumption and additionally finds that memory cells share some of the 608 epigenetic signature of effector cells, so erroneously claims that memory cells are de-609 differentiated effectors. But we show that the optimal initial activation of naïve CD4 + T cells 610 can induce multiple T cell effector and regulator transcription factors, which would likely 611 leave an epigenetic signature in cells destined to become both effector and memory T cells.
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A different view has been that the effector/memory cell fate decision is deterministic and 613 binary, with an extreme example being where an asymmetric cell division generates two 614 daughters, one proliferating to generate effector cells while the other is committed to the 615 memory cell lineage. Our data has similarity to this latter view, except that we did not 616 observe a one-to-one binary fate decision, nor was there any evidence for any asymmetric 617 cell division. Why might this be? We did not use any mitotic inhibitors in our cultures, as 618 these are known to generate artefactual asymmetry during cytokinesis (37). By fixation at 619 37 o C we "froze" any cells in late anaphase/telophase rather than allowing lower temperatures 620 (62), centrifugation or nutrient starvation to disrupt cell structure or cause mitotic spindle 621 collapse which might generate artefactual asymmetry. One limitation was that we were also 622 unable to stain for numb or notch, claimed to be the drivers of asymmetric cell division (63, 623 64), as a number of commercially (polyclonal) available antibodies gave no cell surface 624 staining above background in our hands, and staining for notch signalling with a monoclonal 625 anti-NICD was also unhelpful (not shown). Notwithstanding this limitation, we found that 626 that the effector lineage was tightly linked to uropodium development before any cell 627 division, and while both lineages were generated across a wide range of conditions, the 628 proportion of effector versus memory cells was regulated in a non-linear manner by 629 signalling through both TCR/CD28, acting primarily through PI3K on mTORC1, but also by 630 GITR (TNFRSF18) signalling via mTORC2/pAKTS473 and NFB. Independently, we found 631 that GITR/mTORC2 signalling and uropodium development were associated with an early 632 (pre-division) induction of random combinations of transcription factors for T helper and 633 regulatory cell subsets, which generate an early cohort of poly-functional effector cells. GITR 634 signalling via mTORC2 was important for uropodium expression and effector cell 635 commitment, but it also led to increased expression of NFB in all CD4 + T cells. NFB 636 localisation to the nucleus, however, was seen primarily in the long-lived memory cells. This dual role of GITR co-stimulation suggests it might promote the decision process rather than live/dead aqua staining, and with a CTV dilution equivalent to an average of 4.2 cell 685 divisions ( Figure 12J ). Developing memory cells without uropodia, however, continued to 686 proliferate (more than 8 cell divisions by CTV dilution: Figure 12J ), became quiescent (as 687 indicated by loss of pS6 staining: Figure 13B ), but remained viable and still expressing 688 nuclear NFkB until at least day 10 after stimulation. More importantly, they could harvested, 689 labelled with CTV and re-stimulated, either with CD3/CD28 beads or DC + antigen, to (Figure 4) . The in vitro model also shows that it is the effector cells 715 (with uropodia) that correspond to the high mitochondrial containing population, and that the 716 low mitochondria cells that are missing in tolerant mice are more likely to be memory cells. 717 We also showed many years ago that mice tolerant of a skin graft have an increased, rather 718 than decreased, frequency of circulating (splenic) effector Th1 and Th2 cells (22). Taken 719 together, the immune "defect" in tolerant mice would correspond to a lack of memory cells, 720 so that a secondary challenge only elicits a short-lived, primary-like effector cell response in 721 the circulation that can be adequately controlled by the regulatory foxp3 + T cells residing 722 within the tolerated skin graft tissue.
723
Metabolism and cell fate decisions -cause or effect? 724 We know that there seems to be a strong link between effector T cells and glycolysis, 725 compared to memory cells and regulatory T cells, which are more dependent on oxidative 726 phosphorylation and fatty acid metabolism. The Advanced RPMI medium we used should 727 provide, at least initially, an excess of metabolic precursors for all the different pathways. It 728 contains a defined content of fatty acids, known to be important for effective memory cell 729 differentiation/survival (23, 24, 72), insulin to ensure effective glycolysis thought to be 730 important for effector cells (15, 73) , and a non-labile source of glutamine (important as a 731 carbon source for proliferating T cells). Even so, we found that mTORC1 (pS6) signalling peaked on day 2 (MARKI) or 3 (A1RAG) of culture, after which nutrient limitations Par3 complex, which are the same components that have been claimed to be needed for 918 asymmetric cell divisions (10). It is thought that the uropodium is responsible for the 919 interaction of T cells with other cells, such as antigen presenting cells and targets of 920 cytotoxicity, and therefore expresses high levels of TCR, CD4/8 and relevant adhesion 921 molecules (CD44, CD29). The cytotoxic granules of effector T cells are also contained within 922 the uropodium, and cytokines are secreted from them. Mitochondria, and many other 923 organelles are also concentrated within the uropodium, which contains the bulk of the cell 924 cytoplasm. 
